Press Releases
MaaT Pharma announces successful Initial Public Offering on the regulated market of Euronext Paris
Date :
We are a clinical-stage microbiome therapeutics company aiming to improve survival in cancer.
© 2025 MaaT Pharma. MaaT Pharma’s mission is to restore microbiome function to treat life-threatening diseases
